Case Report
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. May 26, 2023; 11(15): 3619-3624
Published online May 26, 2023. doi: 10.12998/wjcc.v11.i15.3619
Treatment of postherpetic neuralgia by bone marrow aspirate injection: A case report
Takahiro Honda Pazili
Takahiro Honda Pazili, Regenerative Medicine, Department of Cell Therapy, Japan Tokyo Stem Cell Transplant Research Institute, Tokyo 104-0061, Japan
Author contributions: Honda Pazili T did all the work for this paper.
Informed consent statement: Informed written consent for the publication of this report and any accompanying images was obtained from the patient.
Conflict-of-interest statement: The author declares that he has no conflict of interest to disclose.
CARE Checklist (2016) statement: The author has read the CARE Checklist (2016), and the manuscript was prepared and revised according to it.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
Corresponding author: Takahiro Honda Pazili, MD, Doctor, Regenerative Medicine, Department of Cell Therapy, Japan Tokyo Stem Cell Transplant Research Institute, Chuuouku Ginza 4-3-9-8F, Tokyo 104-0061, Japan.
Received: January 29, 2023
Peer-review started: January 29, 2023
First decision: February 28, 2023
Revised: March 27, 2023
Accepted: April 17, 2023
Article in press: April 17, 2023
Published online: May 26, 2023
Core Tip

Core Tip: To our knowledge, this is the first report of bone marrow aspirate concentrates (BMAC) curing post-herpetic neuralgia (PHN). BMAC contains bone marrow mesenchymal stem cells and other important cytokines and has favorable results in treating joint pain. PHN is difficult to cure, and conventional medicines do not work well in most cases. BMAC may serve as a radical treatment. The fact that BMAC was useful for the treatment of PHN indicates that BMAC can be applied for other pain-related conditions.